Clinical Trials

Baptist Cancer Services offers patients participation in clinical trials. Following are the clinical trials currently available. For more information, contact our Baptist Cancer Services Navigator, Tonya Ball, at 601-974-6238. (Updated 3/18/2016)

Breast Cancer

Merrimack - MM302 with Herceptin in advanced metastatic breast cancer

Novartis - Randomized study of Ribociclib in combination with Faslodex for advanced breast cancer

Puma Biotechnology - Neratinib plus Xeloda versus Tykerb plus Xeloda in patients with HER 2 positive metastatic breast cancer who have received two or more regimens for metastatic disease

Bladder Cancer

Genentech -Expanded Access program for patients with locally advanced or metastatic urothelial carcinoma after progression on a platinum chemotherapy regimen

Chronic Lymphocytic Leukemia (CLL)

Pharmacyclics -Observational registry of CLL patients designed to describe treatment patterns and assess patient's quality of life

Non-Small Cell Lung Cancer

Astellas - Randomized phase 3 study of ASP8273 vs. Erlotinib in first- line treatment of advanced NSCLC with EGFR mutations

BMS - Nivolumab in advanced NSCLC as maintenance after induction chemotherapy or as first line treatment with standard of care regimens

 

 

Baptist Flame

Cancer Services Hederman Cancer Center

1-800-948-6262

Find A Doctor

Services

Locations

Baptist Medical Clinic

Patients & Visitors

Learn

Contact Us

Physician Tools

Careers at Baptist

Employee Links

Online Services

At Baptist Health Systems

At Baptist Medical Center

close ×